Todd Pendleton Insider Trading $DLB Dolby Laboratories, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Todd Pendleton.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Todd Pendleton. Todd Pendleton is SVP, Chief Marketing Officer in Dolby Laboratories, Inc. ($DLB).

Todd Pendleton in Dolby Laboratories, Inc.

Trading Symbol: DLB
Industry: PATENT OWNERS & LESSORS [6794]
Position of Todd Pendleton: SVP, Chief Marketing Officer
Holdings: 43,185 shares
Current Value: $2,056,038
Latest Transaction: Feb 24 2021
$DLB Market Capitalization: $4.88B
$DLB Previous Close: $47.61

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Todd Pendleton in Dolby Laboratories, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 24 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM68.4010,229699,66429,946
Feb 24 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS95.0910,229972,64632,95643.2 K to 33 K (-23.69 %)
Feb 24 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM68.4010,229699,66443,18533 K to 43.2 K (+31.04 %)
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM68.402,100143,64040,175
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM62.437,813487,76644,271
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM64.602,250145,35016,500
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS94.132,306217,05532,95635.3 K to 33 K (-6.54 %)
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS94.012,100197,41335,26237.4 K to 35.3 K (-5.62 %)
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM68.402,100143,64037,36235.3 K to 37.4 K (+5.96 %)
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS94.117,813735,25135,26243.1 K to 35.3 K (-18.14 %)
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM62.437,813487,76643,07535.3 K to 43.1 K (+22.16 %)
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS94.002,250211,50035,26237.5 K to 35.3 K (-6.00 %)
Feb 22 2021DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM64.602,250145,35037,51235.3 K to 37.5 K (+6.38 %)
Dec 21 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Payment of ExerciseF91.031,116101,58935,26236.4 K to 35.3 K (-3.07 %)
Dec 17 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA92.0827,2532,509,45627,253
Dec 17 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA0.006,36506,365
Dec 17 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Payment of ExerciseF92.081,153106,16836,37837.5 K to 36.4 K (-3.07 %)
Dec 17 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...GrantA0.0012,731037,53124.8 K to 37.5 K (+51.33 %)
Nov 25 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM64.605,191335,33918,750
Nov 25 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS89.695,191465,56724,80030 K to 24.8 K (-17.31 %)
Nov 25 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM64.605,191335,33929,99124.8 K to 30 K (+20.93 %)
Nov 20 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM62.4326,0411,625,74052,084
Nov 20 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM64.602,309149,16123,941
Nov 20 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS89.872,862257,19724,80027.7 K to 24.8 K (-10.35 %)
Nov 20 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS89.3526,0412,326,81327,66253.7 K to 27.7 K (-48.49 %)
Nov 20 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM62.4326,0411,625,74053,70327.7 K to 53.7 K (+94.14 %)
Nov 20 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS89.802,309207,35127,66230 K to 27.7 K (-7.70 %)
Nov 20 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM64.602,309149,16129,97127.7 K to 30 K (+8.35 %)
Jul 16 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Payment of ExerciseF66.001,51399,85827,66229.2 K to 27.7 K (-5.19 %)
Feb 19 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM62.4346,8752,926,40678,125
Feb 19 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseM64.609,750629,85026,250
Feb 19 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS72.204,333312,84329,17533.5 K to 29.2 K (-12.93 %)
Feb 19 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS72.2846,8753,387,90033,50880.4 K to 33.5 K (-58.31 %)
Feb 19 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM62.4346,8752,926,40680,38333.5 K to 80.4 K (+139.89 %)
Feb 19 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...SellS72.329,750705,16233,50843.3 K to 33.5 K (-22.54 %)
Feb 19 2020DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...BuyM64.609,750629,85043,25833.5 K to 43.3 K (+29.10 %)
Dec 18 2019DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA68.4042,2752,891,61042,275
Dec 18 2019DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA0.004,65004,650
Dec 18 2019DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Payment of ExerciseF68.4077953,28433,50834.3 K to 33.5 K (-2.27 %)
Dec 18 2019DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...GrantA0.009,300034,28725 K to 34.3 K (+37.22 %)
Jul 18 2019DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Payment of ExerciseF65.281,51398,76924,98726.5 K to 25 K (-5.71 %)
Dec 19 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA64.6036,0002,325,60036,000
Dec 19 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA64.6036,0002,325,60036,000
Dec 19 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA64.6018,0001,162,80018,000
Dec 19 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA64.6018,0001,162,80018,000
Dec 19 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...GrantA0.009,000026,50017.5 K to 26.5 K (+51.43 %)
Dec 19 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...GrantA0.009,000026,50017.5 K to 26.5 K (+51.43 %)
Jul 18 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...Option ExerciseA62.43125,0007,803,750125,000
Jul 18 2018DLBDolby Laboratories ...Pendleton ToddSVP, Chief Marketin ...GrantA0.0017,500017,5000 to 17.5 K

Page:   1

Contact us | Follow us on Twitter